Palvella Therapeutics to Present SELVA and TOIVA Results at 2026 PeDRA Conference
The company will also present new pediatric analyses. The headline identifies SELVA as Phase 3 and TOIVA as Phase 2.
Story updates
11:32:47 AM UTC
SquawkNews
Phase 3 SELVA Pediatric Analyses Highlight Improvements in Overall Disease Severity and a Blinded Combined Score of Lesion Height, Vesicle Appearance, and Leaking/BleedingPhase 2 TOIVA Pediatric Analyses Highlight Improvements in Overall Disease Severity and Reductions in Lesion Bleeding in Previou…